OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: Farhad Imam

2 Projects | 1 Researchers | $3,482,360 Invested

2026

Alzheimer's Disease Data Initiative (ADDI)

Farhad Imam

Proteomic Characterization of the Bluefield Cohort

  • Funding Amount: $1,600,560
  • Organization Type:
  • Program: Diagnostics Accelerator
  • Target: Multi-Target
  • Status: Active

2025

Alzheimer's Disease Data Initiative (ADDI)

Farhad Imam

The Global Neurodegeneration Proteomics Consortium: V2 expansion for ADNI and other key AD datasets

  • Funding Amount: $1,881,800
  • Organization Type:
  • Program: Diagnostics Accelerator
  • Target: Other
  • Status: Active